• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8 Back to Search Results
Model Number G8
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Low Readings (2460)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/28/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Device evaluation by manufacturer: a field service engineer (fse) was dispatched to the customer's facility to address the reported issue.Fse confirmed reported problem of biorad control level 3 running low on customer established qc range.Fse replaced the sample loop for the injection valve, performed calibration run and still running low.Customer replaced the column, performed calibration again and qc l3 still running low.Fse replaced the hemolysis & wash solution, performed calibration and ran biorad controls lot# 38541 & 38543 and they completed successfully within customer's established ranges.Fse also ran tosoh controls lot# 7065 and they also completed successfully within acceptable range.Fse successfully completed a 10 times precision on a random normal patient.No further action required by field service.The g8 instrument is functioning as expected.A 13-month complaint history review and service history review for similar complaints for the g8, serial number (b)(4), was performed through aware date.There were two (2) similar complaints identified during the search period, which includes this event.The g8 operator's manual under chapter 1 - introduction and applications, section 1.6 provides detailed instruction on hemolysis & wash solution installation.Quality control: in order to monitor and evaluate the accuracy and precision of the analytical performance, controls should be assayed daily and after column replacement.Tosoh suggests running at least two levels of quality control material.The mean of one should be in the non-diabetic range (4-7% hba1c) with the second in the range of 9-12% hba1c.If the value of one or more control specimens is out of the acceptable range, recalibrate the system and rerun the controls before testing patient samples.Qc materials should be used in accordance with local, state, federal and accredited organizations.Controls should be diluted with hsi hemolysis & wash solution to obtain an optimal total area (ta) in the range of 700-3000.However a ta in the range of 500-4000 is acceptable and reportable for whole blood specimens.The most probable cause of the reported event was due to empty hemolysis & wash solution.
 
Event Description
A customer reported level 3 (l3) bio-rad lot 38540 was running low on customer established quality controls (qc) run on the g8 instrument.Bio-rad lot 38540 target range for l3: 12.42 - 15.17; customer's established range result: 13.3 - 13.9, 13.1 & 13.3.The customer reran with mac controls and l3 was in range.Technical support specialist recommended that customer reestablish their l3 ranges and rerun a sample.The following run completed within acceptable range, but customer insisted on an onsite service.A field service engineer (fse) was dispatched to address the reported event, which resulted in delay in reporting of patient results for hemoglobin a1c (hba1c).There was no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOSOH HLC-723G8 ANALYZER G8
Type of Device
G8
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo, japan 10586 23
JA  1058623
Manufacturer (Section G)
TOSOH CORPORATION (MANUFACTURER)
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo, japan 10586 23
JA   1058623
Manufacturer Contact
doria esquivel
6000 shoreline court
suite 101
south san francisco, CA 94080
6509368123
MDR Report Key8280117
MDR Text Key136147959
Report Number8031673-2018-05440
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K131580
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 01/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Device Catalogue Number021560
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/25/2019
Distributor Facility Aware Date12/28/2018
Device Age7 YR
Event Location Outpatient Treatment Facility
Date Report to Manufacturer01/25/2019
Initial Date Manufacturer Received 12/28/2018
Initial Date FDA Received01/25/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/01/2011
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-